Emergent BioSolutions Q2 EPS $(0.86) Misses $0.37 Estimate, Sales $242.70M Miss $270.94M Estimate
Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $0.37 by 332.43 percent. This is a 360.61 percent decrease over earnings of $0.33 per share